On July 11, 2012, Merus Labs International Inc. acquired Emselex®/Enablex®. Stewart Muglich and Victor Dudas of our Corporate Finance & Securities Group handled the debt facility between Merus and PDL BioPharma Inc., a company that supports the healthcare industry with creative financing solutions, assisted by Amaan Gangji and Kevin MacDonald. The transaction involved counsel from Toronto, New York, Switzerland, the Netherlands and Luxembourg.
Related Content
CW presents to capacity crowd at Buildex 2012
Samantha Ip, Oliver Hanson, Satinder Sidhu and Anna Sekunova from our Construction Group presented at this year’s Buildex Vancouver event on February 9, 2012. Their ... Continued
Marketers Beware: CRTC Issues First Compliance and Enforcement Decision
The CRTC has issued its first compliance and enforcement decision (“Decision“) regarding Canada’s anti-spam legislation (“CASL“).1 In the Decision, the CRTC delves into interpreting CASL ... Continued
Happy International Women’s Day 2024
Each year on March 8th, the world comes together to celebrate the cultural, economic, political, and social achievements of women around the globe. It is ... Continued